Erin Catherine Carter

Insider Reports History

Location
301 Rte 17 North, Ste. 800, Rutherford, NJ
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin Catherine Carter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Glucotrack, Inc. Director Common Stock, par value $0.001 per share 2.15K $10.5K $4.87 Oct 3, 2025 Direct
Glucotrack, Inc. Director Stock option (right to buy) 4.06K Oct 3, 2025 Direct
Glucotrack, Inc. Director Series A Common Warrant 2.08K Nov 14, 2024 Direct
Glucotrack, Inc. Director Convertible Promissory Note 0 Nov 14, 2024 Direct
Glucotrack, Inc. Director Series B Common Warrant 0 Mar 12, 2025 Direct

Insider Reports Filed by Erin Catherine Carter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GCTK Glucotrack, Inc. Mar 25, 2025 4 $0 4 Oct 7, 2025 Director
GCTK Glucotrack, Inc. Dec 31, 2023 10 $180K 4 Mar 31, 2025 Director
GCTK GlucoTrack, Inc. Aug 25, 2023 0 $0 3 Sep 11, 2023 Director